$299 M

PETX Mkt cap, 14-Dec-2018

$21.6 M

Aratana Therapeutics Revenue Q3, 2018
Aratana Therapeutics Gross profit (Q3, 2018)19.4 M
Aratana Therapeutics Gross profit margin (Q3, 2018), %89.9%
Aratana Therapeutics Net income (Q3, 2018)8.8 M
Aratana Therapeutics EBIT (Q3, 2018)9.4 M
Aratana Therapeutics Cash, 30-Sep-201854.3 M

Aratana Therapeutics Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

123.0k767.0k678.0k38.6m25.6m

Revenue growth, %

524%(12%)5586%

Cost of goods sold

108.0k365.0k3.1m16.4m

Gross profit

15.0k313.0k35.4m9.2m

Gross profit Margin, %

12%46%92%36%

R&D expense

10.9m25.0m30.5m15.1m

General and administrative expense

8.6m19.8m27.3m28.9m

Operating expense total

20.0m90.2m69.4m70.0m

Depreciation and amortization

379.0k350.0k

EBIT

(19.9m)(41.6m)(89.5m)(30.8m)(44.5m)

EBIT margin, %

(16149%)(5425%)(13200%)(80%)(174%)

Interest expense

432.0k1.6m3.4m3.5m

Interest income

75.0k189.0k385.0k449.0k

Pre tax profit

(19.7m)(85.8m)(33.6m)(47.5m)

Income tax expense

15.5m1.7m1.7m

Net Income

(26.2m)(38.8m)(84.1m)(33.6m)(47.5m)

Aratana Therapeutics Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

41.1m9.8m26.8m87.3m66.9m

Accounts Receivable

352.0k60.0k87.0k2.4m

Inventories

55.0k427.0k1.3m11.1m13.6m

Current Assets

48.5m99.9m89.0m101.5m85.2m

PP&E

98.0k620.0k2.6m1.9m1.2m

Goodwill

20.8m41.4m39.8m39.4m41.3m

Total Assets

115.5m207.9m147.1m151.4m135.2m

Accounts Payable

2.3m1.5m1.4m7.4m7.5m

Short-term debt

Current Liabilities

16.9m9.5m5.7m34.7m35.5m

Long-term debt

Total Debt

Total Liabilities

29.5m45.5m61.0m55.1m

Additional Paid-in Capital

112.5m255.0m263.9m286.9m321.6m

Retained Earnings

(68.0m)(152.0m)(185.6m)(233.3m)

Total Equity

86.0m181.8m101.6m90.4m80.1m

Financial Leverage

1.3 x1.1 x1.4 x1.7 x1.7 x

Aratana Therapeutics Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.3m)(38.8m)(84.1m)(33.6m)(47.5m)

Depreciation and Amortization

395.0k2.0m1.8m991.0k1.2m

Accounts Receivable

(102.0k)281.0k(27.0k)(2.3m)

Inventories

(372.0k)(879.0k)(15.0m)(3.2m)

Accounts Payable

1.5m(1.1m)(117.0k)6.2m62.0k

Cash From Operating Activities

(16.2m)(32.2m)(38.5m)(11.3m)(38.2m)

Purchases of PP&E

(94.0k)(72.0k)(1.0k)

Cash From Investing Activities

(29.2m)(100.1m)33.7m57.3m(5.8m)

Cash From Financing Activities

72.5m101.0m21.9m14.6m23.5m

Interest Paid

357.0k942.0k

Aratana Therapeutics Ratios

USDY, 2018

Financial Leverage

1.3 x
Report incorrect company information

Aratana Therapeutics Employee Rating

0 votes
Culture & Values
N/A
Work/Life Balance
N/A
Senior Management
N/A
Salary & Benefits
N/A
Career Opportunities
N/A
Source